Sun Pharma Advanced Research Co opened higher at ₹185.78, compared with its previous close of ₹184.85. During today's session, the stock has traded between ₹182.51 and ₹190.00, with an average traded price of ₹186.15. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Sun Pharma Advanced Research Co is now worth
₹ 6,438.00
resulting in a loss of
₹ 3,562.00 (35.62%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+4.20 (+2.27%)
Day High
₹190.00
Day Low
₹182.51
Day Open
₹185.78
Prev Close
₹184.85
Volume
6,91,639
Value Traded
₹12.87 Cr
1W Return
-1.16%
1M Return
-3.55%
3M Return
-28.55%
6M Return
27.44%
1Y Return
41.07%
Market Cap (₹ Cr.)
6,135
PE Ratio
3.80
PB Ratio
4.48
Dividend Yield
-
ROE
116.01%
ROCE
112.03%
Book Value (₹)
41.26
Face Value (₹)
1.00
EPS (TTM)
-0.64
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.16%
6 Week
-
1 Month
-3.55%
3 Month
-28.55%
9 Month
39.77%
CESTAT upholds ₹2,751 lakh CENVAT credit refund for Sun Pharma Advanced Research
CESTAT Mumbai upheld the refund of ₹2,751 lakh in accumulated CENVAT credit for Sun Pharma Advanced Research Company. The tribunal dismissed the Revenue's appeal, confirming the company's entitlement to the refund plus consequential interest. The verdict validates the Order-in-Appeal dated April 27, 2018, concluding a litigation process disclosed in August 2023.
9 days agoSun Pharma Advanced Research Co Q1 Results: Loss widens 6% YoY
Sun Pharma Advanced Research Company Limited reported a Q1FY27 standalone net loss of ₹2,098 lakhs, narrowing from ₹5,203 lakhs in Q1FY26. Revenue jumped 314% YoY to ₹3,992 lakhs due to CMS agreement termination. Consolidated loss was ₹2,078 lakhs. Board approved promoter reclassification.
2mo agoSPARC promoters seek reclassification of 1.85% stake to public category
Sun Pharma Advanced Research Company Ltd received requests on July 27, 2026, from three promoter group members to reclassify 59,79,182 shares (1.85% stake) to the public category. The requests involve Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia, and Mrs. Krishna Vrundavandas Valia. The Board of Directors will review the requests per SEBI Listing Regulations before submitting applications to stock exchanges.
2mo agoSun Pharma Advanced Research Co 21st AGM scheduled on Aug 10
Sun Pharma Advanced Research Company Limited has announced its 21st Annual General Meeting for August 10, 2026, to be held via video conferencing. The Annual Report for FY 2025-26 was dispatched electronically on July 16, 2026. Shareholders can participate via remote e-voting from August 6 to August 9, 2026, with August 3, 2026, set as the record date for eligibility.
2mo agoSun Pharma Advanced Research Co files BRSR for FY 2025-26
Sun Pharma Advanced Research Company Ltd filed its BRSR for FY 2025-26, reporting a workforce of 466 and detailing ESG performance. The company reduced energy and water consumption, maintained zero liquid discharge, and identified key material risks including data security and climate change. No CSR expenditure was required due to prior losses.
2mo agoSun Pharma Advanced Research Co turns profitable on PRV sale
Sun Pharma Advanced Research Company Limited reported a consolidated net profit of ₹1,55,320.43 lakh for FY26, a turnaround from a net loss of ₹34,250.94 lakh in the previous year. The financial improvement was driven by the sale of a Priority Review Voucher (PRV) for USD 195 million. Total income rose to ₹1,88,999.95 lakh from ₹7,355.71 lakh in the previous year.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Sun Pharma Advanced Research Co is now worth
₹ 6,438.00
resulting in a loss of
₹ 3,562.00 (35.62%)
Note: Past profits do not guarantee future returns.
